724 related articles for article (PubMed ID: 7800500)
1. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
[TBL] [Abstract][Full Text] [Related]
2. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
Ohkawa J; Yuyama N; Taira K
Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
[TBL] [Abstract][Full Text] [Related]
3. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
Tiley LS; Madore SJ; Malim MH; Cullen BR
Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
[TBL] [Abstract][Full Text] [Related]
4. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
Sun LQ; Wang L; Gerlach WL; Symonds G
Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
[TBL] [Abstract][Full Text] [Related]
5. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.
Malim MH; Tiley LS; McCarn DF; Rusche JR; Hauber J; Cullen BR
Cell; 1990 Feb; 60(4):675-83. PubMed ID: 2406030
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.
Zhou C; Bahner IC; Larson GP; Zaia JA; Rossi JJ; Kohn EB
Gene; 1994 Nov; 149(1):33-9. PubMed ID: 7958986
[TBL] [Abstract][Full Text] [Related]
8. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
Southgate C; Zapp ML; Green MR
Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
[TBL] [Abstract][Full Text] [Related]
9. Importance of independence in ribozyme reactions: kinetic behavior of trimmed and of simply connected multiple ribozymes with potential activity against human immunodeficiency virus.
Ohkawa J; Yuyama N; Takebe Y; Nishikawa S; Taira K
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11302-6. PubMed ID: 8248243
[TBL] [Abstract][Full Text] [Related]
10. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
Bai J; Banda N; Lee NS; Rossi J; Akkina R
Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
[TBL] [Abstract][Full Text] [Related]
11. Effective anti-hepatitis B virus hammerhead ribozymes derived from multimeric precursors.
Weinberg MS; Ely A; Passman M; Mufamadi SM; Arbuthnot P
Oligonucleotides; 2007; 17(1):104-12. PubMed ID: 17461767
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.
Luo Y; Madore SJ; Parslow TG; Cullen BR; Peterlin BM
J Virol; 1993 Sep; 67(9):5617-22. PubMed ID: 8350414
[TBL] [Abstract][Full Text] [Related]
13. RNA binding by the tat and rev proteins of HIV-1.
Karn J; Dingwall C; Finch JT; Heaphy S; Gait MJ
Biochimie; 1991 Jan; 73(1):9-16. PubMed ID: 1903308
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes.
Bauer G; Valdez P; Kearns K; Bahner I; Wen SF; Zaia JA; Kohn DB
Blood; 1997 Apr; 89(7):2259-67. PubMed ID: 9116267
[TBL] [Abstract][Full Text] [Related]
15. U1 small nuclear RNA chimeric ribozymes with substrate specificity for the Rev pre-mRNA of human immunodeficiency virus.
Michienzi A; Prislei S; Bozzoni I
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7219-24. PubMed ID: 8692972
[TBL] [Abstract][Full Text] [Related]
16. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
17. A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1.
Yamada O; Kraus G; Luznik L; Yu M; Wong-Staal F
J Virol; 1996 Mar; 70(3):1596-601. PubMed ID: 8627679
[TBL] [Abstract][Full Text] [Related]
18. Construction of a novel RNA-transcript-trimming plasmid which can be used both in vitro in place of run-off and (G)-free transcriptions and in vivo as multi-sequences transcription vectors.
Taira K; Nakagawa K; Nishikawa S; Furukawa K
Nucleic Acids Res; 1991 Oct; 19(19):5125-30. PubMed ID: 1923797
[TBL] [Abstract][Full Text] [Related]
19. Preparation of HIV TAR RNA with RNA scissors.
Wyszko E; Fuerste JP; Barciszewska M; Szymanski M; Adamiak R; Erdmann VA; Barciszewski J
J Biochem; 1999 Aug; 126(2):326-32. PubMed ID: 10423525
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
